Neuro-computational look at mood fluctuations in depression and bipolar disorder.
Official title: Neuro-computational Study of Thymic Fluctuations in Mood Disorders - MOODELING
Run by Centre Hospitalier St Anne · NCT07033923 · Data updated 2026-11-12
This tests whether combining brain scans, cognitive tests, and daily smartphone mood tracking can model and help predict mood changes in people with depression or bipolar disorder.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 588 (estimated) |
| Sponsor | Centre Hospitalier St Anne Academic / other |
| Locations | 2 sites (Paris, Paris and 1 other locations) |
| Status | Recruiting |
| Started | July 18, 2024 |
| Main results expected | July 18, 2028 |
| Study ends | July 18, 2029 |
| Registry record updated | September 21, 2026 |
| Trial ID | NCT07033923 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults with a recent (within 12 months) diagnosed depressive episode or a bipolar mood episode who can undergo MRI and commit to daily smartphone monitoring for up to 12 months.
✕Probably not a fit
People who cannot complete daily mobile monitoring for 12 months, are under legal guardianship, or have contraindications to MRI are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The project combines a single neuroimaging session (structural and optional functional MRI) with computerized cognitive tests and a year of daily smartphone-based mood monitoring using a mobile application. Investigators will recruit three groups of about 96 participants each: people with depressive disorder, people with bipolar disorder, and healthy controls. Computational models will be fit to the behavioral and neural data to characterize how mood fluctuates and how those fluctuations relate to brain activity in regions such as the ventromedial prefrontal cortex and anterior insula. The main goal is to determine whether these models can describe real-life mood dynamics and predict subsequent clinical evolution.
Why it matters
Potential benefit: If successful, the approach could produce personalized tools that help clinicians predict mood episodes and tailor monitoring or treatment plans.
How similar studies have gone: Previous neurocomputational work and fMRI studies in healthy volunteers have linked mood signals to vmPFC and anterior insula activity, but translating these findings into clinically useful prediction tools remains largely unproven.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Common between groups (DD, BD, control and GP): * Having given informed and written consent * Being covered by social security For patients with depressive disorder (DD): * Having been diagnosed with characterized depressive episode (F32, F33, F34) according to the ICD-10, by a psychiatrist, or having presented this diagnosis during the past 12 months For patients with bipolar disorder (BD): * Presenting a diagnosis of bipolar mood disorder (F31) according to ICD-10, by a psychiatrist * Having presented a mood episode (F31.0 - F31.6) diagnosed during the past 12 months by a psychiatrist Exclusion Criteria: Common between groups (DD, BD, control and GP): * Inability to carry out daily monitoring on mobile application for 12 months * legal protection measure (guardianship or curatorship) For control group: * Current diagnosis of psychiatric disorder in ICD-10 (F20-F98) or prescription of psychotropic treatment * History of depression (F32) * Syndrome of dependence on a psychoactive substance other than tobacco * Neurological history (in particular history of stroke, coma, epilepsy, neuro- inflammatory, or neuro-degenerative disease) * Inability to carry out daily monitoring on mobile application for 12 months For patients and healthy volunteers for whom an MRI (without injection of contrast agent) is proposed * Contraindication to MRI: cardiac pacemaker not compatible with MRI, heart valve implant, implant or metallic foreign body * Pregnant woman (at the time of MRI)
Where it's running
-
- Groupe hospitalo-universitaire Paris Psychiatrie et Neurosciences
Paris, Paris, France Recruiting -
Assistance Publique - Hôpitaux de Paris GH Pitié-Salpêtrière
Paris, France Recruiting
Study contacts
- Principal investigator: Fabien Vinckier, Dr — GHU Paris Psychiatry & Neurosciences
- Study coordinator: Fabien Vinckier, Pr
- Email: F.VINCKIER@ghu-paris.fr
- Phone: (0) 1 45 65 84 52
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Evaluation of patients with mood and anxiety disorders and healthy volunteers
This study is looking for people with mood and anxiety disorders, as well as healthy volunteers, to see if they can help with research that aims to better understand these conditions.
-
Testing a new drug for treatment-resistant depression
This study is testing a new drug called HNK to see if it can help people with treatment-resistant depression feel better when other medications haven't worked.
-
Investigating the effects of citalopram on brain response to emotions
This study tests how the antidepressant citalopram affects the brain's response to emotions in healthy people by comparing brain scans after taking the medication or a placebo.
-
Heat and cold therapy for reducing depression symptoms
This study is testing whether a combination of heat therapy and a cold water plunge can help reduce depression symptoms in adults with major depressive disorder.
-
Combining psilocybin with accelerated rTMS for treatment-resistant depression
This will test whether a single psilocybin dosing session followed by a short, intensive accelerated rTMS course helps adults with treatment-resistant major depressive disorder.
-
Personalized mobile app for cognitive behavioral therapy
This study is testing if a personalized mobile app for cognitive behavioral therapy can help young people with anxiety, depression, or bipolar disorder just as much as a standard app.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.